Abstract:Ganoderma lucidum (G. lucidum), a traditional Chinese medicine, has been used in cancer prevention for many years. As one of the main components of G. lucidum, G. lucidum polysaccharides (GLPs) showed significant anti‐cancer activity. Previous studies in our laboratory show that GLPs extracted from sporoderm‐broken spores of G. lucidum, significantly inhibited the proliferation and induced apoptosis in colorectal cancer (CRC) cells in vivo and in vitro. However, whether GLPs regulate autophagy in CRC cells is unknown. In the present study, we found that GLPs enhance the level of LC3B and activating autophagy initiation both in HCT116 and HT29 CRC cells as determined by Western blot, transmission electron microscope, and confocal microscope. However, autophagy initiation induced by GLPs was accompanied by impaired degradation of SQSTM1/p62, which suggesting autophagic flux inhibition in CRC cells by GLPs. mRFP‐GFP‐LC3B adenovirus translocation and colocalization analyses confirmed that autophagosome‐lysosome fusion is blocked by GLPs treatment. Furthermore, GLPs inhibited autophagic degradation by inhibiting lysosomal acidification and downregulating the expression of cathepsin B and cathepsin D. Next, we found GLPs induced expression of MAPK/Erk in both CRC cells. Erk inhibitor PD98059 inhibited GLPs‐induced apoptosis and LC3B expression in CRC cells suggesting that Erk activation is partially, at least, responsible for GLPs‐induced autophagy initiation. Importantly, further analysis using flow cytometry revealed that GLPs induced autophagosome accumulation is required for GLP‐induced cytotoxicity. Similar results were obtained using a xenograft mouse model, in which GLPs reduced tumor growth and increased the levels of LC3B and p62 in tumors. Moreover, the levels of cathepsin B and cathepsin D were decreased in tumors from GLP treated mice in vivo. Collectively, these data demonstrate that GLPs inhibit CRC cell proliferation and induce apoptosis through regulation of autophagosome accumulation and autophagic flux inhibition, which may be dependent, at least in part, on MAPK/Erk activation.Support or Funding InformationSupported by Science and Technology Planning Project of Zhejiang Province (Grant No. 2019C02100) and National Natural Science Foundation of China (Grant No. 81473397).This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Ganoderma lucidum polysaccharide exerts anti-tumor activity via MAPK pathways in HL-60 acute leukemia cells

[Ganoderma lucidum polysaccharides promote T lymphocyte infiltration into tumor by regulating expression of ICAM-1 in endothelial cells].

Antitumor Activity and Mechanism in Vivo of Low- Molecular Weight Polysaccharides from Ganoderma Lucidum

Active lipids of Ganoderma lucidum spores-induced apoptosis in human leukemia THP-1 cells via MAPK and PI3K pathways.

Ganoderma lucidum polysaccharide (GLP) enhances antitumor immune response by regulating differentiation and inhibition of MDSCs via a CARD9-NF-κB-IDO pathway

Antitumor activity of enzymatically hydrolyzed Ganoderma lucidum polysaccharide on U14 cervical carcinoma–bearing mice

Potential of a novel polysaccharide preparation (GLPP) from Anhui-grown Ganoderma lucidum in tumor treatment and immunostimulation

Ganoderma lucidum Spore Polysaccharide Inhibits the Growth of Hepatocellular Carcinoma Cells by Altering Macrophage Polarity and Induction of Apoptosis

The anti-hepatocellular carcinoma effects of polysaccharides from Ganoderma lucidum by regulating macrophage polarization via the MAPK/NF-κB signaling pathway.

Antitumor and Immunomodulatory Activities of Ganoderma lucidum Polysaccharides in Glioma-Bearing Rats

Ganoderma lucidum Polysaccharides as An Anti-cancer Agent.

Ganoderma Lucidum Polysaccharides Counteract Inhibition on CD71 and FasL Expression by Culture Supernatant of B16F10 Cells Upon Lymphocyte Activation.

Ganoderma Lucidum Polysaccharide Enzymatic Hydrolysate Suppresses the Growth of Human Colon Cancer Cells Via Inducing Apoptosis

Ganoderma Lucidum Polysaccharides Induce Cytotoxicity in Colorectal Cancer Cells Through Inducing Autophagosome Accumulation and Inhibiting Autophagic Flux

[Effect of Ganoderma Lucidum Polysaccharides on Tumor Cell Nucleotide Content and Cell Cycle in S180 Ascitic Tumor-Bearing Mice].

Structure-activity Relationship and Anticancer Mechanisms of Ganoderma Lucidum Polysaccharides

Structure Identification of Ganoderma lucidum Spore Polysaccharides and Their Antitumor Activity In Vivo

Isolation, Purification, Characterization and Anti-Tumor Activities of Ganoderma Lucidum Polysaccharide

Restoration of the Tumor-Suppressor Function to Mutant P53 by Ganoderma Lucidum Polysaccharides in Colorectal Cancer Cells.

The Pharmacological Rationales and Molecular Mechanisms of Ganoderma lucidum Polysaccharides for the Therapeutic Applications of Multiple Diseases

Polysaccharides isolated from mycelia of Ganoderma lucidum induced on HL 60 cell apoptosis by enhancing macrophage activity